Sands Capital Ventures, LLC Taysha Gene Therapies, Inc. Transaction History
Sands Capital Ventures, LLC
- $261 Million
- Q3 2025
A detailed history of Sands Capital Ventures, LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Sands Capital Ventures, LLC holds 724,873 shares of TSHA stock, worth $3.05 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
724,873
Previous 724,873
-0.0%
Holding current value
$3.05 Million
Previous $1.67 Million
36.38%
% of portfolio
0.87%
Previous 0.54%
Shares
1 transactions
Others Institutions Holding TSHA
# of Institutions
162Shares Held
247MCall Options Held
463KPut Options Held
246K-
Rtw Investments, LP New York, NY24.4MShares$103 Million1.03% of portfolio
-
Ra Capital Management, L.P. Boston, MA23.6MShares$99.2 Million1.27% of portfolio
-
Avoro Capital Advisors LLC New York, NY21.7MShares$91.4 Million0.93% of portfolio
-
Morgan Stanley New York, NY19.3MShares$81.3 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY13.4MShares$56.3 Million0.01% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $204M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...